Vijayakumar Subramaniyan
About Vijayakumar Subramaniyan
Vijayakumar Subramaniyan is the Director of Clinical Evidence Strategy at Boston Scientific, overseeing Medical Affairs in the APAC region since 2021. He has extensive experience in managing global clinical research projects and holds multiple professional certifications in healthcare and management.
Current Position at Boston Scientific
Since 2021, Vijayakumar Subramaniyan has served as the Director of Clinical Evidence Strategy for the Medical Affairs department in the APAC region at Boston Scientific. His role includes leading professional education initiatives to ensure the effective use of scientific evidence and KOL engagement. He plays a crucial role in developing region-specific medical affairs, device registration, and reimbursement policies in line with the company's business objectives. Additionally, he oversees resource management, budget planning, quality control, risk management, and outsourcing vendor management in the region.
Professional Experience at Boston Scientific
Before his current role, Vijayakumar Subramaniyan held multiple positions at Boston Scientific. From 2015 to 2021, he was the Director of Clinical Research & Medical Affairs for the APAC region. Prior to that, he served as the Project Director for Clinical Programs in the AMEA region from 2014 to 2015. During these periods, he focused on therapy- and product-specific evidence strategy planning and stakeholder communication across various regions.
Previous Roles in Clinical Research
Vijayakumar Subramaniyan accumulated extensive experience in clinical research and project management. From 2012 to 2014, he worked at PAREXEL as Senior Project Leader and Regional Project Director in Singapore. Earlier, he held the position of Project Leader, involved in Global Clinical Research Programs, from 2009 to 2012. He also worked at ICON plc as a Clinical Project Manager from 2006 to 2008 and at Quintiles as a Research Associate from 2005 to 2006. His career began at Hoechst and Aventis Pharma, where he worked as a Research Associate from 2002 to 2004.
Educational Background
Vijayakumar Subramaniyan has a solid educational foundation in pharmaceutical sciences and management. He holds a Bachelor of Pharmacy (B.Pharm.) and an MBA from DR MGR Medical University. He also achieved professional certifications in various domains: ICH-GCP, CFR Clinical Trial from National Institute of Health NIDAT-CTN in 2018; Global Healthcare: Improving Quality and Safety from Harvard T.H. Chan School of Public Health in 2017; and Portfolio Management, Governance, and PMO from the University of Washington, also in 2017.
Expertise in Global Project Management
Vijayakumar Subramaniyan has significant expertise in managing global projects, particularly involving the EU and US regions. He is adept at therapy/product-specific evidence strategy planning and stakeholder communication across the AMEA region. His responsibilities include ensuring alignment within cross-functional teams involving Medical Affairs, RA-HEGA, and management teams to facilitate informed decision-making. He is also responsible for developing region-specific medical affairs and policies.